LSD-Like Drug Wins FDA ‘Breakthrough Therapy’ Status For Treatment Of Generalized Anxiety Disorder

Marijuana Moment
By Ben AdlinMar 7, 2024, 5:01 pm248 ptsTop
Promising results from a clinical trial of the LSD-like substance MM120 have persuaded the Food and Drug Administration (FDA) to award it “breakthrough therapy” status as a treatment for generalized anxiety disorder (GAD). The drugmaker behind MM120—Mind Medicine Inc., or MindMed—said in a press release…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 68

Congressional Committee Approves Federal Hemp THC Ban That Stakeholders Say Would Decimate Industry 62

Mature cannabis markets see job losses while emerging states boom 59

What craft and micro producers are doing to stay profitable in a turbulent market 52

Jones Soda calls it quits with Mary Jones, sells canna-beverage biz for US$3M 49

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.